COVID-19: WHO Expects Anti-malarial Drug Hydroxychloroquine Safety Findings By Mid-June

<strong>The World Health Organization (WHO) on Tuesday said that it will carry out a swift review of data on anti-malarial drug hydroxychloroquine by mid-June after the global health body prohibited the use of HCQ in a trial on the treatment of coronavirus COVID-19 patients due to safety concerns.</strong> United States

source https://news.abplive.com/news/world/covid-19-who-expects-anti-malarial-drug-hydroxychloroquine-safety-findings-by-mid-june-1244685